13G Filing: Great Point Partners and Kura Oncology Inc (KURA)

Page 2 of 10 – SEC Filing

CUSIP
No.  50127T109
13G Page
2 of 9 Pages
1.

NAMES OF REPORTING PERSONS

Great Point Partners, LLC

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
(ENTITIES ONLY):

37-1475292

2. CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
3. SEC
USE ONLY
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF SHARES

BENEFICIALLY

OWNED BY EACH

REPORTING PERSON

WITH

5.

SOLE VOTING POWER

0

6.

SHARED VOTING POWER

1,638,461

7.

SOLE DISPOSITIVE POWER

0

8.

SHARED DISPOSITIVE POWER

1,638,461

9.

AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,638,461

10.

CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(See Instructions)

o

11.

PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

5.92%1

12.

TYPE
OF REPORTING PERSON
(See Instructions)

IA

1 Based
on a total of 27,687,986 shares outstanding, as reported by the Issuer in a Prospectus
Supplement filed with the SEC on August 11, 2017.
Follow Kura Oncology Inc. (NASDAQ:KURA)